Search research articles
Contact Us
Filters
Showing results (1381-1390 of 2,078) with videos related to
Page
of 208
Sort By:
Topics in Spinal Cord Injury Rehabilitation
|
September 25, 2019
Effects of High-Intensity Interval Training Versus Moderate-Intensity Training on Cardiometabolic Health Markers in Individuals With Spinal Cord Injury: A Pilot Study
Kyle Graham, Ceren Yarar-Fisher, Jia Li, et al.
HIV Medicine
|
May 7, 2005
The Protease Inhibitor Transfer Study (PROTRA 1): abacavir and efavirenz in combination as a substitute for a protease inhibitor in heavily pretreated HIV-1-infected patients with undetectable plasma viral load
M Bickel, V Rickerts, C Stephan, et al.
Annals of Plastic Surgery
|
April 1, 1996
Effects of deferoxamine on ischemia/reperfusion injury after peripheral nerve compression
Y Li, K D Bickel, M J Im, et al.
European Journal of Emergency Medicine : Official Journal of the European Society for Emergency Medicine
|
November 9, 2005
Severe rhabdomyolysis, acute renal failure and posterior encephalopathy after 'magic mushroom' abuse
Markus Bickel, Tilmann Ditting, Henrik Watz, et al.
Deutsche Medizinische Wochenschrift (1946)
|
November 13, 2009
[Novel influenza H1N1/2009: virus transmission among health care worker]
S Wicker, H F Rabenau, M Bickel, et al.
Chromosoma
|
October 3, 2007
Functional links between Drosophila Nipped-B and cohesin in somatic and meiotic cells
Maria Gause, Hayley A Webber, Ziva Misulovin, et al.
The Journal of Antimicrobial Chemotherapy
|
September 25, 2009
Once-daily treatment with saquinavir mesylate (2000 mg) and ritonavir (100 mg) together with a fixed-dose combination of abacavir/lamivudine (600/300 mg) or tenofovir/emtricitabine (245/200 mg) in HIV-1-infected patients
M Bickel, A Bodtländer, G K Knecht, et al.
HIV Clinical Trials
|
July 10, 2013
Pharmacokinetics and pharmacodynamics of etravirine 400 mg once daily in treatment-naïve patients
Giovanni Di Perri, Bruce Green, Glynn Morrish, et al.
Developmental Cognitive Neuroscience
|
April 26, 2022
Neural cognitive control moderates the longitudinal link between hedonia and substance use across adolescence
Morgan Lindenmuth, Toria Herd, Alexis Brieant, et al.
Environmental Science & Technology
|
August 7, 2025
The Thioredoxin System Powers ArsM-Mediated Arsenite Methylation in <i>Hymenobacter edaphi</i>
Xue-Ting Li, Jie Shen, David Bickel, et al.
Page
of 208
Search research articles
Search
Showing results (1381-1390 of 2,078) with videos related to
Sort By:
Page
of 208
Topics in Spinal Cord Injury Rehabilitation
|
September 25, 2019
Effects of High-Intensity Interval Training Versus Moderate-Intensity Training on Cardiometabolic Health Markers in Individuals With Spinal Cord Injury: A Pilot Study
Kyle Graham, Ceren Yarar-Fisher, Jia Li, et al.
HIV Medicine
|
May 7, 2005
The Protease Inhibitor Transfer Study (PROTRA 1): abacavir and efavirenz in combination as a substitute for a protease inhibitor in heavily pretreated HIV-1-infected patients with undetectable plasma viral load
M Bickel, V Rickerts, C Stephan, et al.
Annals of Plastic Surgery
|
April 1, 1996
Effects of deferoxamine on ischemia/reperfusion injury after peripheral nerve compression
Y Li, K D Bickel, M J Im, et al.
European Journal of Emergency Medicine : Official Journal of the European Society for Emergency Medicine
|
November 9, 2005
Severe rhabdomyolysis, acute renal failure and posterior encephalopathy after 'magic mushroom' abuse
Markus Bickel, Tilmann Ditting, Henrik Watz, et al.
Deutsche Medizinische Wochenschrift (1946)
|
November 13, 2009
[Novel influenza H1N1/2009: virus transmission among health care worker]
S Wicker, H F Rabenau, M Bickel, et al.
Chromosoma
|
October 3, 2007
Functional links between Drosophila Nipped-B and cohesin in somatic and meiotic cells
Maria Gause, Hayley A Webber, Ziva Misulovin, et al.
The Journal of Antimicrobial Chemotherapy
|
September 25, 2009
Once-daily treatment with saquinavir mesylate (2000 mg) and ritonavir (100 mg) together with a fixed-dose combination of abacavir/lamivudine (600/300 mg) or tenofovir/emtricitabine (245/200 mg) in HIV-1-infected patients
M Bickel, A Bodtländer, G K Knecht, et al.
HIV Clinical Trials
|
July 10, 2013
Pharmacokinetics and pharmacodynamics of etravirine 400 mg once daily in treatment-naïve patients
Giovanni Di Perri, Bruce Green, Glynn Morrish, et al.
Developmental Cognitive Neuroscience
|
April 26, 2022
Neural cognitive control moderates the longitudinal link between hedonia and substance use across adolescence
Morgan Lindenmuth, Toria Herd, Alexis Brieant, et al.
Environmental Science & Technology
|
August 7, 2025
The Thioredoxin System Powers ArsM-Mediated Arsenite Methylation in <i>Hymenobacter edaphi</i>
Xue-Ting Li, Jie Shen, David Bickel, et al.
Page
of 208